[HTML] nih.gov

[HTML][HTML] Comparison of the benefits of celecoxib combined with anticancer therapy in advanced non-small cell lung cancer: A meta-analysis

W Zhang, L Yi, J Shen, H Zhang, P Luo… - Journal of Cancer, 2020 - ncbi.nlm.nih.gov
Background: Studies have reported that advanced NSCLC benefits from celecoxib
combined with systematic treatment. However, the optimal combination with different …
被引用次数：8 相关文章

Comparison of the benefits of celecoxib combined with anticancer therapy in advanced non-small cell lung cancer: A meta-analysis

W Zhang, L Yi, J Shen, H Zhang, P Luo… - Journal of …, 2020 - search.proquest.com
Background: Studies have reported that advanced NSCLC benefits from celecoxib
combined with systematic treatment. However, the optimal combination with different …

Comparison of the benefits of celecoxib combined with anticancer therapy in advanced non-small cell lung cancer: A meta-analysis.

W Zhang, L Yi, J Shen, H Zhang, P Luo… - Journal of Cancer, 2020 - europepmc.org
Background: Studies have reported that advanced NSCLC benefits from celecoxib
combined with systematic treatment. However, the optimal combination with different …
[PDF] semanticscholar.org

[PDF][PDF] Comparison of the benefits of celecoxib combined with anticancer therapy in advanced non-small cell lung cancer: A meta-analysis

W Zhang, L Yi, J Shen, H Zhang, P Luo… - Journal of …, 2020 - pdfs.semanticscholar.org
Background: Studies have reported that advanced NSCLC benefits from celecoxib
combined with systematic treatment. However, the optimal combination with different …

Comparison of the benefits of celecoxib combined with anticancer therapy in advanced non-small cell lung cancer: A meta-analysis

W Zhang, L Yi, J Shen, H Zhang, P Luo… - Journal of …, 2020 - pubmed.ncbi.nlm.nih.gov
Background: Studies have reported that advanced NSCLC benefits from celecoxib
combined with systematic treatment. However, the optimal combination with different …
[HTML] jcancer.org

[HTML][HTML] Comparison of the benefits of celecoxib combined with anticancer therapy in advanced non-small cell lung cancer: A meta-analysis

W Zhang, L Yi, J Shen, H Zhang, P Luo, J Zhang - Journal of Cancer, 2020 - jcancer.org
Background: Studies have reported that advanced NSCLC benefits from celecoxib
combined with systematic treatment. However, the optimal combination with different …